It is suspected that humans have hundreds of susceptibility genes for obesity. In July, OMR will have some of the answers for you in its summary of a new obesity gene experiment presented at a conference last month, and comments from one of the team researchers. Two years ago when fenfluramine and dexfenfluramine were removed from the market, dire predictions of death and expensive chronic disease were made. In this most recent follow-up of Redux patients presented at a conference last month, it appears the small amount of damage is receding. Resting metabolic rate and obesity.
Studies show conflicting results on energy expenditure and obesity.
Read OMR's summary of one such study this month. If you want to hear about the latest breakthroughs in obesity research OMR is indispensable. Don't miss out. Reserve your copy of the July issue today , by becoming an OMR subscriber . Copyright 1997-2001, all rights reserved.